Sea Crest Wealth Management, LLC Cue Biopharma, Inc. Transaction History
Sea Crest Wealth Management, LLC
- $882 Million
- Q3 2025
A detailed history of Sea Crest Wealth Management, LLC transactions in Cue Biopharma, Inc. stock. As of the latest transaction made, Sea Crest Wealth Management, LLC holds 10,000 shares of CUE stock, worth $6,300. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,000
Previous 13,000
23.08%
Holding current value
$6,300
Previous $8,000
12.5%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding CUE
# of Institutions
53Shares Held
18.4MCall Options Held
0Put Options Held
0-
Bleichroeder LP New York, NY6.82MShares$4.3 Million1.28% of portfolio
-
Catalytic Wealth Ria, LLC Cambridge, MA3.43MShares$2.16 Million0.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.04MShares$1.91 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA801KShares$504,4830.0% of portfolio
-
Black Rock Inc. New York, NY757KShares$476,7430.0% of portfolio
About Cue Biopharma, Inc.
- Ticker CUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,381,700
- Market Cap $22.3M
- Description
- Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...